CD137, an attractive candidate for the immunotherapy of lung cancer

Immunotherapy has become a hotspot in cancer therapy in recent years. Several immune checkpoints inhibitors have been used to treat lung cancer. CD137 is a kind of costimulatory molecule that mediates T cell activation, which regulates the activity of immune cells in a variety of physiological and p...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Sci
Main Authors: Ye, Lingyun, Jia, Keyi, Wang, Lei, Li, Wei, Chen, Bin, Liu, Yu, Wang, Hao, Zhao, Sha, He, Yayi, Zhou, Caicun
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Review Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226203/
https://ncbi.nlm.nih.gov/pubmed/32073704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14354
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items